Therapeutic Options for Coronavirus Disease 2019 (COVID-19): Where Are We Now?

ABSTRACT:

Purpose of review

Rapidly evolving treatment paradigms of coronavirus disease 2019 (COVID-19) introduce challenges for clinicians to keep up with the pace of published literature and to critically appraise the voluminous data produced. This review summarizes the clinical evidence from key studies examining the place of therapy of recommended drugs and management strategies for COVID-19.

Recent findings

The global magnitude and duration of the pandemic have resulted in a flurry of interventional treatment trials evaluating both novel and repurposed drugs targeting various aspects of the viral life cycle. Additionally, clinical observations have documented various stages or phases of COVID-19 and underscored the importance of timing for the efficacy of studied therapies. Since

SUBMITTER: Bae EY 

PROVIDER: S-EPMC8665318 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature